Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 1022 studies with search of: | "Docetaxel" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
|
||||
2 | Recruiting |
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
|
||||
3 | Completed |
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
|
||||
4 | Completed |
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
|
||||
5 | Recruiting |
Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients
|
||||
6 | Recruiting |
Study of Docetaxel/Gemcitabine Followed by Chemo-Radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
|
||||
7 | Active, not recruiting |
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
|
||||
8 | Recruiting |
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
|
||||
9 | Active, not recruiting |
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
|
||||
10 | Recruiting |
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
|
||||
11 | Active, not recruiting |
Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
|
||||
12 | Active, not recruiting |
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
|
||||
13 | Recruiting |
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
|
||||
14 | Completed |
Docetaxel in Non Small Cell Lung Cancer (NSCLC)
|
||||
15 | Terminated |
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
|
||||
16 | Completed |
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
|
||||
17 | Completed |
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for c-Stage IB-II Non-Small Cell Lung Cancer (NSCLC)
|
||||
18 | Recruiting |
Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens
|
||||
19 | Terminated |
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
|
||||
20 | Withdrawn |
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |